[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2262195A - Aminoline-n-oxide antimicrobials for use against (h. pylori) infections - Google Patents

Aminoline-n-oxide antimicrobials for use against (h. pylori) infections

Info

Publication number
AU2262195A
AU2262195A AU22621/95A AU2262195A AU2262195A AU 2262195 A AU2262195 A AU 2262195A AU 22621/95 A AU22621/95 A AU 22621/95A AU 2262195 A AU2262195 A AU 2262195A AU 2262195 A AU2262195 A AU 2262195A
Authority
AU
Australia
Prior art keywords
aminoline
pylori
antimicrobials
infections
oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22621/95A
Inventor
Sandra Lynn Lacey
Graham Walter Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RPMS Technology Ltd
Original Assignee
RPMS Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RPMS Technology Ltd filed Critical RPMS Technology Ltd
Publication of AU2262195A publication Critical patent/AU2262195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22621/95A 1994-04-20 1995-04-20 Aminoline-n-oxide antimicrobials for use against (h. pylori) infections Abandoned AU2262195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9407869 1994-04-20
GB9407869A GB9407869D0 (en) 1994-04-20 1994-04-20 Antimicrobial compounds
PCT/GB1995/000886 WO1995028929A1 (en) 1994-04-20 1995-04-20 Aminoline-n-oxide antimicrobials for use against h. pylori infections

Publications (1)

Publication Number Publication Date
AU2262195A true AU2262195A (en) 1995-11-16

Family

ID=10753854

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22621/95A Abandoned AU2262195A (en) 1994-04-20 1995-04-20 Aminoline-n-oxide antimicrobials for use against (h. pylori) infections

Country Status (4)

Country Link
AU (1) AU2262195A (en)
GB (1) GB9407869D0 (en)
WO (1) WO1995028929A1 (en)
ZA (1) ZA953209B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080757A (en) * 1996-06-06 2000-06-27 Pfizer Inc Antibiotic quinolones and derivatives
WO1999061438A1 (en) * 1998-05-23 1999-12-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
IN190017B (en) 1999-01-25 2003-05-31 Panacea Biotech Ltd
US20020177715A1 (en) * 2000-08-31 2002-11-28 Pesci Everett C. Novel autoinducer molecules and uses therefor
US6576625B2 (en) 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
GB202209867D0 (en) * 2022-07-05 2022-08-17 Univ Nottingham Disruption of epithelial barriers for molecular delivery enhancement or extraction of extracellular fluids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59210021A (en) * 1983-05-12 1984-11-28 Kyowa Hakko Kogyo Co Ltd Preventing and treating agent for disease caused by lipoxygenase metabolite

Also Published As

Publication number Publication date
ZA953209B (en) 1996-01-03
GB9407869D0 (en) 1994-06-15
WO1995028929A1 (en) 1995-11-02

Similar Documents

Publication Publication Date Title
AU2530295A (en) File transfer mechanism
EP0644506A3 (en) Tape printing system.
EP0665676A3 (en) Printing system.
EP0665675A3 (en) Printing system.
EP0635369A3 (en) Intermediate transfer surface application system.
EP0665677A3 (en) Printing system.
AU3770697A (en) 2- and 2,5-substituted phenylketoenols
AU1744895A (en) Limited-traceability systems
AU2681895A (en) 8-aryl-1,6-naphthyridin-5-ones
AU3891095A (en) X-y-omicron positioning mechanism
AU7138394A (en) N,n-diacylpiperazines
AU3794595A (en) Pharmaceutical, orally applicable composition
AU3794795A (en) Pharmaceutical, orally applicable composition
AU4519496A (en) Improved printing system
EP0676766A3 (en) Wide databus architecture.
EP0663607A3 (en) Camera.
EP0790218A3 (en) Transfer mechanism
AU2262195A (en) Aminoline-n-oxide antimicrobials for use against (h. pylori) infections
AU1630895A (en) Treatment of H. pylori infections
AU7845098A (en) Pharmaceutical compositions comprising a 4-arylcoumarin for the treatment f vir al infections
AU7686394A (en) Rectally-administered, epileptic-seizure-inhibiting composition
AU5871598A (en) (h. pylori) antigens
AU1515492A (en) Low loss, broadband stripline-to-microstrip transition
AU3614995A (en) Connection device e.g. for bone parts
AU3607995A (en) Microbicides